nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—ABCB1—kidney cancer	0.118	1	CbGaD
Doxepin—ORM1—Erlotinib—kidney cancer	0.0493	0.094	CbGbCtD
Doxepin—HTR2B—Sorafenib—kidney cancer	0.0426	0.0813	CbGbCtD
Doxepin—ABCB1—Temsirolimus—kidney cancer	0.0289	0.0552	CbGbCtD
Doxepin—KCNH2—Sunitinib—kidney cancer	0.0286	0.0546	CbGbCtD
Doxepin—HTR2C—Sorafenib—kidney cancer	0.0277	0.0529	CbGbCtD
Doxepin—CYP2D6—Temsirolimus—kidney cancer	0.0273	0.052	CbGbCtD
Doxepin—CYP3A4—Everolimus—kidney cancer	0.0257	0.049	CbGbCtD
Doxepin—CYP1A2—Pazopanib—kidney cancer	0.0174	0.0332	CbGbCtD
Doxepin—CYP3A4—Temsirolimus—kidney cancer	0.0173	0.0331	CbGbCtD
Doxepin—CYP2C9—Capecitabine—kidney cancer	0.0163	0.0312	CbGbCtD
Doxepin—ABCB1—Pazopanib—kidney cancer	0.0152	0.029	CbGbCtD
Doxepin—CYP2D6—Pazopanib—kidney cancer	0.0143	0.0273	CbGbCtD
Doxepin—ABCB1—Dactinomycin—kidney cancer	0.0139	0.0265	CbGbCtD
Doxepin—CYP1A2—Erlotinib—kidney cancer	0.0124	0.0237	CbGbCtD
Doxepin—ABCB1—Gemcitabine—kidney cancer	0.011	0.021	CbGbCtD
Doxepin—CYP2C19—Sorafenib—kidney cancer	0.0109	0.0209	CbGbCtD
Doxepin—ABCB1—Erlotinib—kidney cancer	0.0109	0.0207	CbGbCtD
Doxepin—CYP2C9—Paclitaxel—kidney cancer	0.0102	0.0195	CbGbCtD
Doxepin—CYP2D6—Erlotinib—kidney cancer	0.0102	0.0195	CbGbCtD
Doxepin—CYP1A2—Sorafenib—kidney cancer	0.0101	0.0192	CbGbCtD
Doxepin—ABCB1—Paclitaxel—kidney cancer	0.00993	0.0189	CbGbCtD
Doxepin—CYP3A4—Pazopanib—kidney cancer	0.00911	0.0174	CbGbCtD
Doxepin—CYP2C9—Sorafenib—kidney cancer	0.00909	0.0173	CbGbCtD
Doxepin—ABCB1—Sorafenib—kidney cancer	0.00882	0.0168	CbGbCtD
Doxepin—ABCB1—Vinblastine—kidney cancer	0.00871	0.0166	CbGbCtD
Doxepin—ABCB1—Vincristine—kidney cancer	0.00857	0.0163	CbGbCtD
Doxepin—CYP2D6—Sorafenib—kidney cancer	0.00831	0.0159	CbGbCtD
Doxepin—CYP2D6—Vinblastine—kidney cancer	0.00821	0.0157	CbGbCtD
Doxepin—CHRM3—ureter—kidney cancer	0.0078	0.231	CbGeAlD
Doxepin—ABCB1—Sunitinib—kidney cancer	0.00715	0.0136	CbGbCtD
Doxepin—CYP3A4—Erlotinib—kidney cancer	0.0065	0.0124	CbGbCtD
Doxepin—CYP3A4—Paclitaxel—kidney cancer	0.00595	0.0114	CbGbCtD
Doxepin—ABCB1—Doxorubicin—kidney cancer	0.00535	0.0102	CbGbCtD
Doxepin—CYP3A4—Sorafenib—kidney cancer	0.00529	0.0101	CbGbCtD
Doxepin—CYP3A4—Vinblastine—kidney cancer	0.00522	0.00996	CbGbCtD
Doxepin—CYP3A4—Vincristine—kidney cancer	0.00513	0.00979	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—kidney cancer	0.00504	0.00962	CbGbCtD
Doxepin—CYP3A4—Sunitinib—kidney cancer	0.00428	0.00817	CbGbCtD
Doxepin—Olopatadine—S100A1—kidney cancer	0.00349	0.645	CrCbGaD
Doxepin—CYP3A4—Doxorubicin—kidney cancer	0.00321	0.00612	CbGbCtD
Doxepin—CYP2C19—urine—kidney cancer	0.00236	0.0698	CbGeAlD
Doxepin—CYP1A2—urine—kidney cancer	0.00192	0.057	CbGeAlD
Doxepin—CYP2C9—urine—kidney cancer	0.00183	0.0541	CbGeAlD
Doxepin—HTR2A—urine—kidney cancer	0.0015	0.0446	CbGeAlD
Doxepin—CYP3A4—urine—kidney cancer	0.00139	0.0413	CbGeAlD
Doxepin—CYP2D6—urine—kidney cancer	0.00137	0.0406	CbGeAlD
Doxepin—HRH2—cardiac atrium—kidney cancer	0.00104	0.0308	CbGeAlD
Doxepin—ADRA1B—renal system—kidney cancer	0.00101	0.03	CbGeAlD
Doxepin—ADRA1B—kidney—kidney cancer	0.00098	0.029	CbGeAlD
Doxepin—Dimetacrine—ACHE—kidney cancer	0.000928	0.171	CrCbGaD
Doxepin—HTR2B—cortex of kidney—kidney cancer	0.000649	0.0192	CbGeAlD
Doxepin—CHRM3—renal system—kidney cancer	0.00062	0.0184	CbGeAlD
Doxepin—HTR1A—renal system—kidney cancer	0.000618	0.0183	CbGeAlD
Doxepin—CHRM3—kidney—kidney cancer	0.0006	0.0178	CbGeAlD
Doxepin—ADRA2C—nephron tubule—kidney cancer	0.000597	0.0177	CbGeAlD
Doxepin—ADRA1A—renal system—kidney cancer	0.00057	0.0169	CbGeAlD
Doxepin—KCNH2—renal system—kidney cancer	0.00055	0.0163	CbGeAlD
Doxepin—SLC6A2—gonad—kidney cancer	0.000549	0.0163	CbGeAlD
Doxepin—ADRA2C—renal system—kidney cancer	0.000543	0.0161	CbGeAlD
Doxepin—ADRA2C—kidney—kidney cancer	0.000525	0.0155	CbGeAlD
Doxepin—ADRA2C—cortex of kidney—kidney cancer	0.000511	0.0151	CbGeAlD
Doxepin—KCNH2—cardiac atrium—kidney cancer	0.000493	0.0146	CbGeAlD
Doxepin—ADRA2C—cardiac atrium—kidney cancer	0.000486	0.0144	CbGeAlD
Doxepin—CYP1A2—renal system—kidney cancer	0.000471	0.014	CbGeAlD
Doxepin—ADRA2A—cortex of kidney—kidney cancer	0.000408	0.0121	CbGeAlD
Doxepin—ADRA2A—gonad—kidney cancer	0.000388	0.0115	CbGeAlD
Doxepin—ADRA2A—cardiac atrium—kidney cancer	0.000388	0.0115	CbGeAlD
Doxepin—HTR2A—renal system—kidney cancer	0.000368	0.0109	CbGeAlD
Doxepin—HTR2A—kidney—kidney cancer	0.000356	0.0105	CbGeAlD
Doxepin—CYP3A4—renal system—kidney cancer	0.000341	0.0101	CbGeAlD
Doxepin—CYP2D6—renal system—kidney cancer	0.000335	0.00994	CbGeAlD
Doxepin—HTR2A—gonad—kidney cancer	0.00033	0.00978	CbGeAlD
Doxepin—CYP3A4—kidney—kidney cancer	0.00033	0.00976	CbGeAlD
Doxepin—CYP2D6—kidney—kidney cancer	0.000324	0.00961	CbGeAlD
Doxepin—Clomipramine—GSTP1—kidney cancer	0.000272	0.0503	CrCbGaD
Doxepin—ABCB1—nephron tubule—kidney cancer	0.000265	0.00786	CbGeAlD
Doxepin—ABCB1—renal system—kidney cancer	0.000241	0.00715	CbGeAlD
Doxepin—ABCB1—kidney—kidney cancer	0.000233	0.00691	CbGeAlD
Doxepin—ABCB1—cortex of kidney—kidney cancer	0.000227	0.00673	CbGeAlD
Doxepin—ABCB1—gonad—kidney cancer	0.000216	0.00641	CbGeAlD
Doxepin—Nortriptyline—PTGS1—kidney cancer	0.000147	0.0272	CrCbGaD
Doxepin—Diphenhydramine—PTGS1—kidney cancer	0.000136	0.0251	CrCbGaD
Doxepin—Nausea—Erlotinib—kidney cancer	9.93e-05	0.000386	CcSEcCtD
Doxepin—Alopecia—Capecitabine—kidney cancer	9.92e-05	0.000386	CcSEcCtD
Doxepin—Dry mouth—Paclitaxel—kidney cancer	9.91e-05	0.000386	CcSEcCtD
Doxepin—Diarrhoea—Sunitinib—kidney cancer	9.9e-05	0.000385	CcSEcCtD
Doxepin—Ataxia—Doxorubicin—kidney cancer	9.84e-05	0.000382	CcSEcCtD
Doxepin—Mental disorder—Capecitabine—kidney cancer	9.83e-05	0.000382	CcSEcCtD
Doxepin—Asthenia—Dactinomycin—kidney cancer	9.83e-05	0.000382	CcSEcCtD
Doxepin—Confusional state—Paclitaxel—kidney cancer	9.8e-05	0.000381	CcSEcCtD
Doxepin—Erythema—Capecitabine—kidney cancer	9.77e-05	0.00038	CcSEcCtD
Doxepin—Malnutrition—Capecitabine—kidney cancer	9.77e-05	0.00038	CcSEcCtD
Doxepin—Oedema—Paclitaxel—kidney cancer	9.72e-05	0.000378	CcSEcCtD
Doxepin—Abdominal pain—Vincristine—kidney cancer	9.67e-05	0.000376	CcSEcCtD
Doxepin—Body temperature increased—Vincristine—kidney cancer	9.67e-05	0.000376	CcSEcCtD
Doxepin—Infection—Paclitaxel—kidney cancer	9.65e-05	0.000375	CcSEcCtD
Doxepin—Flatulence—Capecitabine—kidney cancer	9.63e-05	0.000374	CcSEcCtD
Doxepin—Dysgeusia—Capecitabine—kidney cancer	9.57e-05	0.000372	CcSEcCtD
Doxepin—Dizziness—Sunitinib—kidney cancer	9.57e-05	0.000372	CcSEcCtD
Doxepin—Feeling abnormal—Gemcitabine—kidney cancer	9.57e-05	0.000372	CcSEcCtD
Doxepin—Shock—Paclitaxel—kidney cancer	9.56e-05	0.000372	CcSEcCtD
Doxepin—Vomiting—Sorafenib—kidney cancer	9.56e-05	0.000372	CcSEcCtD
Doxepin—Nervous system disorder—Paclitaxel—kidney cancer	9.53e-05	0.000371	CcSEcCtD
Doxepin—Hypokalaemia—Doxorubicin—kidney cancer	9.52e-05	0.00037	CcSEcCtD
Doxepin—Thrombocytopenia—Paclitaxel—kidney cancer	9.52e-05	0.00037	CcSEcCtD
Doxepin—Tachycardia—Paclitaxel—kidney cancer	9.48e-05	0.000369	CcSEcCtD
Doxepin—Rash—Sorafenib—kidney cancer	9.48e-05	0.000369	CcSEcCtD
Doxepin—Dermatitis—Sorafenib—kidney cancer	9.47e-05	0.000368	CcSEcCtD
Doxepin—Back pain—Capecitabine—kidney cancer	9.45e-05	0.000368	CcSEcCtD
Doxepin—Breast disorder—Doxorubicin—kidney cancer	9.45e-05	0.000368	CcSEcCtD
Doxepin—Skin disorder—Paclitaxel—kidney cancer	9.44e-05	0.000367	CcSEcCtD
Doxepin—Headache—Sorafenib—kidney cancer	9.42e-05	0.000366	CcSEcCtD
Doxepin—Muscle spasms—Capecitabine—kidney cancer	9.39e-05	0.000365	CcSEcCtD
Doxepin—Hyperhidrosis—Paclitaxel—kidney cancer	9.39e-05	0.000365	CcSEcCtD
Doxepin—Diarrhoea—Dactinomycin—kidney cancer	9.37e-05	0.000364	CcSEcCtD
Doxepin—Nasopharyngitis—Doxorubicin—kidney cancer	9.35e-05	0.000364	CcSEcCtD
Doxepin—Anorexia—Paclitaxel—kidney cancer	9.26e-05	0.00036	CcSEcCtD
Doxepin—Alanine aminotransferase increased—Doxorubicin—kidney cancer	9.23e-05	0.000359	CcSEcCtD
Doxepin—Vision blurred—Capecitabine—kidney cancer	9.21e-05	0.000358	CcSEcCtD
Doxepin—Vomiting—Sunitinib—kidney cancer	9.2e-05	0.000358	CcSEcCtD
Doxepin—Body temperature increased—Gemcitabine—kidney cancer	9.18e-05	0.000357	CcSEcCtD
Doxepin—Tremor—Capecitabine—kidney cancer	9.16e-05	0.000356	CcSEcCtD
Doxepin—Rash—Sunitinib—kidney cancer	9.12e-05	0.000355	CcSEcCtD
Doxepin—Dermatitis—Sunitinib—kidney cancer	9.11e-05	0.000354	CcSEcCtD
Doxepin—Hypotension—Paclitaxel—kidney cancer	9.08e-05	0.000353	CcSEcCtD
Doxepin—Ill-defined disorder—Capecitabine—kidney cancer	9.07e-05	0.000353	CcSEcCtD
Doxepin—Headache—Sunitinib—kidney cancer	9.06e-05	0.000352	CcSEcCtD
Doxepin—Asthma—Doxorubicin—kidney cancer	9.04e-05	0.000352	CcSEcCtD
Doxepin—Influenza—Doxorubicin—kidney cancer	9.04e-05	0.000352	CcSEcCtD
Doxepin—Anaemia—Capecitabine—kidney cancer	9.03e-05	0.000351	CcSEcCtD
Doxepin—Hypersensitivity—Vincristine—kidney cancer	9.01e-05	0.000351	CcSEcCtD
Doxepin—Eosinophilia—Doxorubicin—kidney cancer	8.95e-05	0.000348	CcSEcCtD
Doxepin—Nausea—Sorafenib—kidney cancer	8.93e-05	0.000347	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	8.85e-05	0.000344	CcSEcCtD
Doxepin—Malaise—Capecitabine—kidney cancer	8.81e-05	0.000343	CcSEcCtD
Doxepin—Insomnia—Paclitaxel—kidney cancer	8.79e-05	0.000342	CcSEcCtD
Doxepin—Vertigo—Capecitabine—kidney cancer	8.78e-05	0.000341	CcSEcCtD
Doxepin—Asthenia—Vincristine—kidney cancer	8.78e-05	0.000341	CcSEcCtD
Doxepin—Syncope—Capecitabine—kidney cancer	8.76e-05	0.000341	CcSEcCtD
Doxepin—Leukopenia—Capecitabine—kidney cancer	8.75e-05	0.00034	CcSEcCtD
Doxepin—Paraesthesia—Paclitaxel—kidney cancer	8.73e-05	0.000339	CcSEcCtD
Doxepin—Vomiting—Dactinomycin—kidney cancer	8.71e-05	0.000339	CcSEcCtD
Doxepin—Bronchitis—Doxorubicin—kidney cancer	8.69e-05	0.000338	CcSEcCtD
Doxepin—Dyspnoea—Paclitaxel—kidney cancer	8.66e-05	0.000337	CcSEcCtD
Doxepin—Somnolence—Paclitaxel—kidney cancer	8.64e-05	0.000336	CcSEcCtD
Doxepin—Palpitations—Capecitabine—kidney cancer	8.64e-05	0.000336	CcSEcCtD
Doxepin—Rash—Dactinomycin—kidney cancer	8.63e-05	0.000336	CcSEcCtD
Doxepin—Nausea—Sunitinib—kidney cancer	8.59e-05	0.000334	CcSEcCtD
Doxepin—Loss of consciousness—Capecitabine—kidney cancer	8.59e-05	0.000334	CcSEcCtD
Doxepin—Pancytopenia—Doxorubicin—kidney cancer	8.59e-05	0.000334	CcSEcCtD
Doxepin—Dyspepsia—Paclitaxel—kidney cancer	8.55e-05	0.000333	CcSEcCtD
Doxepin—Cough—Capecitabine—kidney cancer	8.53e-05	0.000332	CcSEcCtD
Doxepin—Dysuria—Doxorubicin—kidney cancer	8.45e-05	0.000329	CcSEcCtD
Doxepin—Decreased appetite—Paclitaxel—kidney cancer	8.45e-05	0.000329	CcSEcCtD
Doxepin—Hypertension—Capecitabine—kidney cancer	8.44e-05	0.000328	CcSEcCtD
Doxepin—Upper respiratory tract infection—Doxorubicin—kidney cancer	8.4e-05	0.000327	CcSEcCtD
Doxepin—Gastrointestinal disorder—Paclitaxel—kidney cancer	8.39e-05	0.000326	CcSEcCtD
Doxepin—Fatigue—Paclitaxel—kidney cancer	8.38e-05	0.000326	CcSEcCtD
Doxepin—Diarrhoea—Vincristine—kidney cancer	8.37e-05	0.000326	CcSEcCtD
Doxepin—Pollakiuria—Doxorubicin—kidney cancer	8.35e-05	0.000325	CcSEcCtD
Doxepin—Asthenia—Gemcitabine—kidney cancer	8.33e-05	0.000324	CcSEcCtD
Doxepin—Arthralgia—Capecitabine—kidney cancer	8.32e-05	0.000324	CcSEcCtD
Doxepin—Chest pain—Capecitabine—kidney cancer	8.32e-05	0.000324	CcSEcCtD
Doxepin—Myalgia—Capecitabine—kidney cancer	8.32e-05	0.000324	CcSEcCtD
Doxepin—Pain—Paclitaxel—kidney cancer	8.31e-05	0.000323	CcSEcCtD
Doxepin—Constipation—Paclitaxel—kidney cancer	8.31e-05	0.000323	CcSEcCtD
Doxepin—Anxiety—Capecitabine—kidney cancer	8.29e-05	0.000322	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	8.26e-05	0.000321	CcSEcCtD
Doxepin—Weight increased—Doxorubicin—kidney cancer	8.23e-05	0.00032	CcSEcCtD
Doxepin—Discomfort—Capecitabine—kidney cancer	8.22e-05	0.00032	CcSEcCtD
Doxepin—Pruritus—Gemcitabine—kidney cancer	8.21e-05	0.000319	CcSEcCtD
Doxepin—Dry mouth—Capecitabine—kidney cancer	8.14e-05	0.000316	CcSEcCtD
Doxepin—Nausea—Dactinomycin—kidney cancer	8.13e-05	0.000316	CcSEcCtD
Doxepin—Pneumonia—Doxorubicin—kidney cancer	8.11e-05	0.000315	CcSEcCtD
Doxepin—Dizziness—Vincristine—kidney cancer	8.09e-05	0.000315	CcSEcCtD
Doxepin—Infestation NOS—Doxorubicin—kidney cancer	8.06e-05	0.000313	CcSEcCtD
Doxepin—Drowsiness—Doxorubicin—kidney cancer	8.06e-05	0.000313	CcSEcCtD
Doxepin—Infestation—Doxorubicin—kidney cancer	8.06e-05	0.000313	CcSEcCtD
Doxepin—Confusional state—Capecitabine—kidney cancer	8.04e-05	0.000313	CcSEcCtD
Doxepin—Feeling abnormal—Paclitaxel—kidney cancer	8.01e-05	0.000311	CcSEcCtD
Doxepin—Oedema—Capecitabine—kidney cancer	7.98e-05	0.00031	CcSEcCtD
Doxepin—Gastrointestinal pain—Paclitaxel—kidney cancer	7.95e-05	0.000309	CcSEcCtD
Doxepin—Diarrhoea—Gemcitabine—kidney cancer	7.94e-05	0.000309	CcSEcCtD
Doxepin—Infection—Capecitabine—kidney cancer	7.92e-05	0.000308	CcSEcCtD
Doxepin—Neuropathy peripheral—Doxorubicin—kidney cancer	7.9e-05	0.000307	CcSEcCtD
Doxepin—Jaundice—Doxorubicin—kidney cancer	7.86e-05	0.000306	CcSEcCtD
Doxepin—Stomatitis—Doxorubicin—kidney cancer	7.86e-05	0.000306	CcSEcCtD
Doxepin—Shock—Capecitabine—kidney cancer	7.85e-05	0.000305	CcSEcCtD
Doxepin—Urinary tract infection—Doxorubicin—kidney cancer	7.83e-05	0.000305	CcSEcCtD
Doxepin—Nervous system disorder—Capecitabine—kidney cancer	7.82e-05	0.000304	CcSEcCtD
Doxepin—Thrombocytopenia—Capecitabine—kidney cancer	7.81e-05	0.000304	CcSEcCtD
Doxepin—Tachycardia—Capecitabine—kidney cancer	7.78e-05	0.000303	CcSEcCtD
Doxepin—Vomiting—Vincristine—kidney cancer	7.78e-05	0.000303	CcSEcCtD
Doxepin—Skin disorder—Capecitabine—kidney cancer	7.75e-05	0.000301	CcSEcCtD
Doxepin—Sweating—Doxorubicin—kidney cancer	7.73e-05	0.000301	CcSEcCtD
Doxepin—Urticaria—Paclitaxel—kidney cancer	7.72e-05	0.0003	CcSEcCtD
Doxepin—Rash—Vincristine—kidney cancer	7.71e-05	0.0003	CcSEcCtD
Doxepin—Hyperhidrosis—Capecitabine—kidney cancer	7.71e-05	0.0003	CcSEcCtD
Doxepin—Dermatitis—Vincristine—kidney cancer	7.71e-05	0.0003	CcSEcCtD
Doxepin—Abdominal pain—Paclitaxel—kidney cancer	7.68e-05	0.000299	CcSEcCtD
Doxepin—Body temperature increased—Paclitaxel—kidney cancer	7.68e-05	0.000299	CcSEcCtD
Doxepin—Headache—Vincristine—kidney cancer	7.67e-05	0.000298	CcSEcCtD
Doxepin—Hepatobiliary disease—Doxorubicin—kidney cancer	7.62e-05	0.000296	CcSEcCtD
Doxepin—Anorexia—Capecitabine—kidney cancer	7.6e-05	0.000296	CcSEcCtD
Doxepin—Sinusitis—Doxorubicin—kidney cancer	7.56e-05	0.000294	CcSEcCtD
Doxepin—Agranulocytosis—Doxorubicin—kidney cancer	7.52e-05	0.000293	CcSEcCtD
Doxepin—Hypotension—Capecitabine—kidney cancer	7.45e-05	0.00029	CcSEcCtD
Doxepin—Vomiting—Gemcitabine—kidney cancer	7.38e-05	0.000287	CcSEcCtD
Doxepin—Bradycardia—Doxorubicin—kidney cancer	7.37e-05	0.000286	CcSEcCtD
Doxepin—Clomipramine—ABCB1—kidney cancer	7.32e-05	0.0135	CrCbGaD
Doxepin—Rash—Gemcitabine—kidney cancer	7.32e-05	0.000285	CcSEcCtD
Doxepin—Dermatitis—Gemcitabine—kidney cancer	7.31e-05	0.000284	CcSEcCtD
Doxepin—Chlorprothixene—ABCB1—kidney cancer	7.29e-05	0.0135	CrCbGaD
Doxepin—Headache—Gemcitabine—kidney cancer	7.27e-05	0.000283	CcSEcCtD
Doxepin—Nausea—Vincristine—kidney cancer	7.27e-05	0.000283	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Capecitabine—kidney cancer	7.27e-05	0.000283	CcSEcCtD
Doxepin—Hepatitis—Doxorubicin—kidney cancer	7.24e-05	0.000281	CcSEcCtD
Doxepin—Insomnia—Capecitabine—kidney cancer	7.21e-05	0.000281	CcSEcCtD
Doxepin—Hypoaesthesia—Doxorubicin—kidney cancer	7.2e-05	0.00028	CcSEcCtD
Doxepin—Pharyngitis—Doxorubicin—kidney cancer	7.18e-05	0.000279	CcSEcCtD
Doxepin—Paraesthesia—Capecitabine—kidney cancer	7.16e-05	0.000278	CcSEcCtD
Doxepin—Hypersensitivity—Paclitaxel—kidney cancer	7.16e-05	0.000278	CcSEcCtD
Doxepin—Urinary tract disorder—Doxorubicin—kidney cancer	7.15e-05	0.000278	CcSEcCtD
Doxepin—Oedema peripheral—Doxorubicin—kidney cancer	7.13e-05	0.000277	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—kidney cancer	7.11e-05	0.000277	CcSEcCtD
Doxepin—Dyspnoea—Capecitabine—kidney cancer	7.11e-05	0.000277	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—kidney cancer	7.09e-05	0.000276	CcSEcCtD
Doxepin—Dyspepsia—Capecitabine—kidney cancer	7.02e-05	0.000273	CcSEcCtD
Doxepin—Asthenia—Paclitaxel—kidney cancer	6.97e-05	0.000271	CcSEcCtD
Doxepin—Decreased appetite—Capecitabine—kidney cancer	6.93e-05	0.00027	CcSEcCtD
Doxepin—Nausea—Gemcitabine—kidney cancer	6.89e-05	0.000268	CcSEcCtD
Doxepin—Gastrointestinal disorder—Capecitabine—kidney cancer	6.89e-05	0.000268	CcSEcCtD
Doxepin—Fatigue—Capecitabine—kidney cancer	6.88e-05	0.000267	CcSEcCtD
Doxepin—Pruritus—Paclitaxel—kidney cancer	6.88e-05	0.000267	CcSEcCtD
Doxepin—Pain—Capecitabine—kidney cancer	6.82e-05	0.000265	CcSEcCtD
Doxepin—Constipation—Capecitabine—kidney cancer	6.82e-05	0.000265	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—kidney cancer	6.76e-05	0.000263	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—kidney cancer	6.75e-05	0.000262	CcSEcCtD
Doxepin—Trimipramine—ABCB1—kidney cancer	6.74e-05	0.0124	CrCbGaD
Doxepin—Cardiac disorder—Doxorubicin—kidney cancer	6.72e-05	0.000261	CcSEcCtD
Doxepin—Flushing—Doxorubicin—kidney cancer	6.72e-05	0.000261	CcSEcCtD
Doxepin—Diarrhoea—Paclitaxel—kidney cancer	6.65e-05	0.000259	CcSEcCtD
Doxepin—Feeling abnormal—Capecitabine—kidney cancer	6.57e-05	0.000256	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—kidney cancer	6.57e-05	0.000255	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—kidney cancer	6.54e-05	0.000254	CcSEcCtD
Doxepin—Gastrointestinal pain—Capecitabine—kidney cancer	6.52e-05	0.000254	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—kidney cancer	6.52e-05	0.000254	CcSEcCtD
Doxepin—Chills—Doxorubicin—kidney cancer	6.49e-05	0.000252	CcSEcCtD
Doxepin—Promethazine—ABCB1—kidney cancer	6.49e-05	0.012	CrCbGaD
Doxepin—Arrhythmia—Doxorubicin—kidney cancer	6.46e-05	0.000251	CcSEcCtD
Doxepin—Dizziness—Paclitaxel—kidney cancer	6.43e-05	0.00025	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—kidney cancer	6.39e-05	0.000249	CcSEcCtD
Doxepin—Mental disorder—Doxorubicin—kidney cancer	6.34e-05	0.000247	CcSEcCtD
Doxepin—Urticaria—Capecitabine—kidney cancer	6.34e-05	0.000246	CcSEcCtD
Doxepin—Abdominal pain—Capecitabine—kidney cancer	6.3e-05	0.000245	CcSEcCtD
Doxepin—Body temperature increased—Capecitabine—kidney cancer	6.3e-05	0.000245	CcSEcCtD
Doxepin—Erythema—Doxorubicin—kidney cancer	6.3e-05	0.000245	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—kidney cancer	6.3e-05	0.000245	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—kidney cancer	6.21e-05	0.000241	CcSEcCtD
Doxepin—Tension—Doxorubicin—kidney cancer	6.18e-05	0.00024	CcSEcCtD
Doxepin—Vomiting—Paclitaxel—kidney cancer	6.18e-05	0.00024	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—kidney cancer	6.17e-05	0.00024	CcSEcCtD
Doxepin—Rash—Paclitaxel—kidney cancer	6.13e-05	0.000238	CcSEcCtD
Doxepin—Dermatitis—Paclitaxel—kidney cancer	6.12e-05	0.000238	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—kidney cancer	6.12e-05	0.000238	CcSEcCtD
Doxepin—Back pain—Doxorubicin—kidney cancer	6.09e-05	0.000237	CcSEcCtD
Doxepin—Headache—Paclitaxel—kidney cancer	6.09e-05	0.000237	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—kidney cancer	6.06e-05	0.000236	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—kidney cancer	5.94e-05	0.000231	CcSEcCtD
Doxepin—Desipramine—ABCB1—kidney cancer	5.89e-05	0.0109	CrCbGaD
Doxepin—Hypersensitivity—Capecitabine—kidney cancer	5.88e-05	0.000229	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—kidney cancer	5.84e-05	0.000227	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—kidney cancer	5.82e-05	0.000226	CcSEcCtD
Doxepin—Agitation—Doxorubicin—kidney cancer	5.79e-05	0.000225	CcSEcCtD
Doxepin—Nausea—Paclitaxel—kidney cancer	5.77e-05	0.000224	CcSEcCtD
Doxepin—Asthenia—Capecitabine—kidney cancer	5.72e-05	0.000223	CcSEcCtD
Doxepin—Malaise—Doxorubicin—kidney cancer	5.68e-05	0.000221	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—kidney cancer	5.66e-05	0.00022	CcSEcCtD
Doxepin—Syncope—Doxorubicin—kidney cancer	5.65e-05	0.00022	CcSEcCtD
Doxepin—Pruritus—Capecitabine—kidney cancer	5.64e-05	0.000219	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—kidney cancer	5.64e-05	0.000219	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—kidney cancer	5.57e-05	0.000216	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—kidney cancer	5.54e-05	0.000215	CcSEcCtD
Doxepin—Cough—Doxorubicin—kidney cancer	5.5e-05	0.000214	CcSEcCtD
Doxepin—Convulsion—Doxorubicin—kidney cancer	5.46e-05	0.000212	CcSEcCtD
Doxepin—Diarrhoea—Capecitabine—kidney cancer	5.46e-05	0.000212	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—kidney cancer	5.44e-05	0.000211	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—kidney cancer	5.36e-05	0.000209	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—kidney cancer	5.36e-05	0.000209	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—kidney cancer	5.36e-05	0.000209	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—kidney cancer	5.34e-05	0.000208	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	5.33e-05	0.000207	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—kidney cancer	5.3e-05	0.000206	CcSEcCtD
Doxepin—Dizziness—Capecitabine—kidney cancer	5.27e-05	0.000205	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—kidney cancer	5.24e-05	0.000204	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—kidney cancer	5.18e-05	0.000202	CcSEcCtD
Doxepin—Oedema—Doxorubicin—kidney cancer	5.14e-05	0.0002	CcSEcCtD
Doxepin—Infection—Doxorubicin—kidney cancer	5.11e-05	0.000199	CcSEcCtD
Doxepin—Vomiting—Capecitabine—kidney cancer	5.07e-05	0.000197	CcSEcCtD
Doxepin—Shock—Doxorubicin—kidney cancer	5.06e-05	0.000197	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—kidney cancer	5.04e-05	0.000196	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—kidney cancer	5.03e-05	0.000196	CcSEcCtD
Doxepin—Rash—Capecitabine—kidney cancer	5.03e-05	0.000196	CcSEcCtD
Doxepin—Dermatitis—Capecitabine—kidney cancer	5.02e-05	0.000195	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—kidney cancer	5.02e-05	0.000195	CcSEcCtD
Doxepin—Headache—Capecitabine—kidney cancer	5e-05	0.000194	CcSEcCtD
Doxepin—Imipramine—ABCB1—kidney cancer	5e-05	0.00923	CrCbGaD
Doxepin—Skin disorder—Doxorubicin—kidney cancer	4.99e-05	0.000194	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—kidney cancer	4.97e-05	0.000193	CcSEcCtD
Doxepin—Amitriptyline—ABCB1—kidney cancer	4.96e-05	0.00917	CrCbGaD
Doxepin—Anorexia—Doxorubicin—kidney cancer	4.9e-05	0.000191	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—kidney cancer	4.8e-05	0.000187	CcSEcCtD
Doxepin—Nausea—Capecitabine—kidney cancer	4.74e-05	0.000184	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.68e-05	0.000182	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—kidney cancer	4.65e-05	0.000181	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—kidney cancer	4.62e-05	0.00018	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—kidney cancer	4.58e-05	0.000178	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—kidney cancer	4.57e-05	0.000178	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—kidney cancer	4.53e-05	0.000176	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—kidney cancer	4.47e-05	0.000174	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—kidney cancer	4.44e-05	0.000173	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—kidney cancer	4.43e-05	0.000172	CcSEcCtD
Doxepin—Constipation—Doxorubicin—kidney cancer	4.4e-05	0.000171	CcSEcCtD
Doxepin—Pain—Doxorubicin—kidney cancer	4.4e-05	0.000171	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—kidney cancer	4.24e-05	0.000165	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—kidney cancer	4.2e-05	0.000163	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—kidney cancer	4.08e-05	0.000159	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—kidney cancer	4.06e-05	0.000158	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—kidney cancer	4.06e-05	0.000158	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—kidney cancer	3.79e-05	0.000147	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—kidney cancer	3.69e-05	0.000143	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—kidney cancer	3.64e-05	0.000141	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—kidney cancer	3.52e-05	0.000137	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—kidney cancer	3.4e-05	0.000132	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—kidney cancer	3.27e-05	0.000127	CcSEcCtD
Doxepin—Rash—Doxorubicin—kidney cancer	3.24e-05	0.000126	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—kidney cancer	3.24e-05	0.000126	CcSEcCtD
Doxepin—Headache—Doxorubicin—kidney cancer	3.22e-05	0.000125	CcSEcCtD
Doxepin—Nausea—Doxorubicin—kidney cancer	3.05e-05	0.000119	CcSEcCtD
Doxepin—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	3.35e-06	5.46e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CCND1—kidney cancer	3.35e-06	5.46e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—ERBB2—kidney cancer	3.35e-06	5.45e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—PIK3CA—kidney cancer	3.34e-06	5.45e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—JUN—kidney cancer	3.34e-06	5.45e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL2—kidney cancer	3.34e-06	5.44e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—PIK3CA—kidney cancer	3.33e-06	5.43e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CTNNB1—kidney cancer	3.33e-06	5.43e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MYC—kidney cancer	3.33e-06	5.43e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTEN—kidney cancer	3.33e-06	5.42e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—RAF1—kidney cancer	3.33e-06	5.42e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	3.32e-06	5.42e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—RAF1—kidney cancer	3.32e-06	5.41e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	3.32e-06	5.41e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CTNNB1—kidney cancer	3.32e-06	5.4e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—RELA—kidney cancer	3.31e-06	5.4e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—RAF1—kidney cancer	3.31e-06	5.39e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—RELA—kidney cancer	3.31e-06	5.39e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MTOR—kidney cancer	3.3e-06	5.38e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—RAF1—kidney cancer	3.3e-06	5.38e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MYC—kidney cancer	3.29e-06	5.37e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—RELA—kidney cancer	3.29e-06	5.37e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—ERBB2—kidney cancer	3.29e-06	5.36e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	3.29e-06	5.36e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL2—kidney cancer	3.29e-06	5.36e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—ERBB2—kidney cancer	3.28e-06	5.35e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—RELA—kidney cancer	3.28e-06	5.35e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	3.28e-06	5.35e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—ERBB2—kidney cancer	3.27e-06	5.33e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—RAF1—kidney cancer	3.27e-06	5.32e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—ERBB2—kidney cancer	3.26e-06	5.32e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—RAF1—kidney cancer	3.26e-06	5.31e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CCND1—kidney cancer	3.26e-06	5.31e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MAPK1—kidney cancer	3.26e-06	5.31e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—RELA—kidney cancer	3.25e-06	5.3e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.25e-06	5.3e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—JUN—kidney cancer	3.25e-06	5.3e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PTEN—kidney cancer	3.25e-06	5.29e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MTOR—kidney cancer	3.25e-06	5.29e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—RELA—kidney cancer	3.24e-06	5.28e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MTOR—kidney cancer	3.24e-06	5.28e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PTEN—kidney cancer	3.23e-06	5.27e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—ERBB2—kidney cancer	3.23e-06	5.27e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MTOR—kidney cancer	3.23e-06	5.26e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CTNNB1—kidney cancer	3.23e-06	5.26e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MAPK1—kidney cancer	3.22e-06	5.25e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	3.22e-06	5.25e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MTOR—kidney cancer	3.22e-06	5.25e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCND1—kidney cancer	3.21e-06	5.22e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—JUN—kidney cancer	3.2e-06	5.21e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MTOR—kidney cancer	3.19e-06	5.2e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	3.19e-06	5.19e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MTOR—kidney cancer	3.18e-06	5.18e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—KRAS—kidney cancer	3.18e-06	5.18e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	3.17e-06	5.17e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PTEN—kidney cancer	3.14e-06	5.12e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.12e-06	5.09e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—POMC—kidney cancer	3.11e-06	5.07e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CDKN1B—kidney cancer	3.1e-06	5.05e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MYC—kidney cancer	3.1e-06	5.05e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—PIK3CA—kidney cancer	3.1e-06	5.05e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PTEN—kidney cancer	3.09e-06	5.04e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—KRAS—kidney cancer	3.08e-06	5.01e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTEN—kidney cancer	3.05e-06	4.98e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	3.05e-06	4.97e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	3.05e-06	4.97e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—KRAS—kidney cancer	3.04e-06	4.96e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CDKN1B—kidney cancer	3.04e-06	4.96e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—kidney cancer	3.04e-06	4.95e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—POMC—kidney cancer	3.04e-06	4.95e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	3.03e-06	4.94e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL2—kidney cancer	3.03e-06	4.94e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	3.03e-06	4.94e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RAF1—kidney cancer	3.03e-06	4.93e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	3.02e-06	4.92e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—RELA—kidney cancer	3.01e-06	4.91e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TP53—kidney cancer	3e-06	4.88e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	2.99e-06	4.88e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	2.99e-06	4.88e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	2.98e-06	4.86e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL2—kidney cancer	2.98e-06	4.86e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL2—kidney cancer	2.98e-06	4.85e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2—kidney cancer	2.97e-06	4.83e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2—kidney cancer	2.96e-06	4.82e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCND1—kidney cancer	2.96e-06	4.82e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MTOR—kidney cancer	2.96e-06	4.82e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—JUN—kidney cancer	2.95e-06	4.81e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—kidney cancer	2.93e-06	4.78e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2—kidney cancer	2.93e-06	4.77e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CTNNB1—kidney cancer	2.93e-06	4.77e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2—kidney cancer	2.92e-06	4.76e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	2.92e-06	4.76e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—kidney cancer	2.92e-06	4.76e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCND1—kidney cancer	2.91e-06	4.74e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—JUN—kidney cancer	2.9e-06	4.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCND1—kidney cancer	2.9e-06	4.73e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—JUN—kidney cancer	2.9e-06	4.72e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCND1—kidney cancer	2.89e-06	4.71e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—JUN—kidney cancer	2.89e-06	4.7e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCND1—kidney cancer	2.88e-06	4.7e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	2.88e-06	4.69e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTP1—kidney cancer	2.88e-06	4.69e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—JUN—kidney cancer	2.88e-06	4.69e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK3—kidney cancer	2.88e-06	4.69e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CTNNB1—kidney cancer	2.87e-06	4.68e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	2.86e-06	4.67e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—KRAS—kidney cancer	2.86e-06	4.66e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—POMC—kidney cancer	2.86e-06	4.66e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCND1—kidney cancer	2.86e-06	4.65e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	2.86e-06	4.65e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PTEN—kidney cancer	2.85e-06	4.65e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—JUN—kidney cancer	2.85e-06	4.64e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCND1—kidney cancer	2.85e-06	4.64e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—JUN—kidney cancer	2.84e-06	4.63e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—kidney cancer	2.84e-06	4.63e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—POMC—kidney cancer	2.84e-06	4.62e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	2.83e-06	4.61e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—PIK3CA—kidney cancer	2.83e-06	4.61e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TP53—kidney cancer	2.83e-06	4.6e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	2.82e-06	4.59e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PTEN—kidney cancer	2.81e-06	4.57e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PTEN—kidney cancer	2.8e-06	4.56e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	2.8e-06	4.56e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MYC—kidney cancer	2.8e-06	4.56e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	2.79e-06	4.55e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PTEN—kidney cancer	2.79e-06	4.55e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PTEN—kidney cancer	2.78e-06	4.53e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK3—kidney cancer	2.78e-06	4.52e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	2.77e-06	4.52e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK3—kidney cancer	2.76e-06	4.5e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PTEN—kidney cancer	2.76e-06	4.49e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PTEN—kidney cancer	2.75e-06	4.48e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MAPK1—kidney cancer	2.74e-06	4.46e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—kidney cancer	2.73e-06	4.46e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCB1—kidney cancer	2.73e-06	4.44e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—kidney cancer	2.71e-06	4.42e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—kidney cancer	2.71e-06	4.41e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—kidney cancer	2.7e-06	4.4e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK3—kidney cancer	2.69e-06	4.38e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—kidney cancer	2.69e-06	4.38e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.67e-06	4.35e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—kidney cancer	2.65e-06	4.32e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTM1—kidney cancer	2.65e-06	4.31e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—kidney cancer	2.65e-06	4.31e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	2.64e-06	4.31e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MAPK1—kidney cancer	2.64e-06	4.3e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—JUN—kidney cancer	2.64e-06	4.3e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	2.63e-06	4.29e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MAPK1—kidney cancer	2.63e-06	4.28e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	2.62e-06	4.27e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—kidney cancer	2.61e-06	4.26e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KRAS—kidney cancer	2.58e-06	4.21e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—kidney cancer	2.58e-06	4.2e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—kidney cancer	2.57e-06	4.19e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK1—kidney cancer	2.56e-06	4.16e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTEN—kidney cancer	2.55e-06	4.16e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—kidney cancer	2.54e-06	4.15e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—kidney cancer	2.54e-06	4.13e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—kidney cancer	2.53e-06	4.12e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—kidney cancer	2.52e-06	4.11e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	2.52e-06	4.1e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—kidney cancer	2.51e-06	4.1e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.51e-06	4.09e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KRAS—kidney cancer	2.49e-06	4.07e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—kidney cancer	2.49e-06	4.06e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	2.48e-06	4.04e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KRAS—kidney cancer	2.48e-06	4.04e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—kidney cancer	2.48e-06	4.04e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK3—kidney cancer	2.44e-06	3.97e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—POMC—kidney cancer	2.42e-06	3.95e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—kidney cancer	2.42e-06	3.95e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KRAS—kidney cancer	2.41e-06	3.93e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK3—kidney cancer	2.4e-06	3.91e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK3—kidney cancer	2.39e-06	3.9e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK3—kidney cancer	2.39e-06	3.89e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK3—kidney cancer	2.38e-06	3.87e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KRAS—kidney cancer	2.38e-06	3.87e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—kidney cancer	2.37e-06	3.87e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—kidney cancer	2.37e-06	3.86e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK3—kidney cancer	2.35e-06	3.84e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	2.35e-06	3.83e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—kidney cancer	2.35e-06	3.83e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—kidney cancer	2.33e-06	3.8e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—kidney cancer	2.33e-06	3.79e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—kidney cancer	2.32e-06	3.78e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK1—kidney cancer	2.32e-06	3.78e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—kidney cancer	2.31e-06	3.77e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	2.31e-06	3.76e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—kidney cancer	2.3e-06	3.74e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—kidney cancer	2.29e-06	3.73e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—kidney cancer	2.29e-06	3.73e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—kidney cancer	2.28e-06	3.72e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK1—kidney cancer	2.28e-06	3.72e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—kidney cancer	2.28e-06	3.72e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—kidney cancer	2.28e-06	3.72e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK1—kidney cancer	2.28e-06	3.71e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK1—kidney cancer	2.27e-06	3.7e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK1—kidney cancer	2.26e-06	3.69e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—kidney cancer	2.26e-06	3.69e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK1—kidney cancer	2.24e-06	3.65e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	2.23e-06	3.64e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—kidney cancer	2.22e-06	3.61e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—kidney cancer	2.22e-06	3.61e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—kidney cancer	2.21e-06	3.59e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KRAS—kidney cancer	2.19e-06	3.57e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	2.18e-06	3.56e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	2.18e-06	3.56e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTEN—kidney cancer	2.16e-06	3.53e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KRAS—kidney cancer	2.16e-06	3.51e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—kidney cancer	2.15e-06	3.51e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KRAS—kidney cancer	2.15e-06	3.5e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—kidney cancer	2.15e-06	3.5e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KRAS—kidney cancer	2.14e-06	3.49e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KRAS—kidney cancer	2.14e-06	3.48e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—kidney cancer	2.12e-06	3.46e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KRAS—kidney cancer	2.12e-06	3.45e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTEN—kidney cancer	2.11e-06	3.44e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—kidney cancer	2.11e-06	3.44e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KRAS—kidney cancer	2.11e-06	3.44e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	2.08e-06	3.38e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—kidney cancer	2.01e-06	3.28e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTEN—kidney cancer	1.99e-06	3.24e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	1.98e-06	3.23e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—kidney cancer	1.98e-06	3.22e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTEN—kidney cancer	1.97e-06	3.21e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	1.97e-06	3.21e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	1.96e-06	3.2e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KRAS—kidney cancer	1.96e-06	3.2e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—kidney cancer	1.95e-06	3.17e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.94e-06	3.17e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.94e-06	3.16e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—kidney cancer	1.93e-06	3.15e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—kidney cancer	1.92e-06	3.12e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—kidney cancer	1.91e-06	3.11e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—kidney cancer	1.91e-06	3.1e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—kidney cancer	1.9e-06	3.09e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—kidney cancer	1.88e-06	3.06e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.88e-06	3.06e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—POMC—kidney cancer	1.87e-06	3.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.8e-06	2.94e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.74e-06	2.84e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTEN—kidney cancer	1.69e-06	2.75e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.53e-06	2.49e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—kidney cancer	1.49e-06	2.43e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—kidney cancer	1.49e-06	2.43e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.4e-06	2.29e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.39e-06	2.27e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTEN—kidney cancer	1.3e-06	2.12e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.19e-06	1.94e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.18e-07	1.5e-05	CbGpPWpGaD
